{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:06:41Z","timestamp":1789189601722,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.020","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:53:56Z","timestamp":1787068436000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-0563","authenticated-orcid":false,"given":"Muhammad Umair","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kasaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-1347","authenticated-orcid":false,"given":"Tahereh","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-7339","authenticated-orcid":false,"given":"Muhammad Kashif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Forghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hediyeh","family":"Alemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Khavandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Rukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-9138","authenticated-orcid":false,"given":"Khalid","family":"Halahleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Ola","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-4796","authenticated-orcid":false,"given":"Joseph P.","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moazzam","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.jtct.2026.08.020_bib0001","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2010-07-259358","article-title":"Who is fit for allogeneic transplantation?","volume":"116","author":"Deeg","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jtct.2026.08.020_bib0002","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.020_bib0003","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/jcm4061240","article-title":"Alternative donor transplantation for acute myeloid leukemia","volume":"4","author":"Bejanyan","year":"2015","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.020_bib0004","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00396","article-title":"Composite GRFS and CRFS outcomes after adult alternative donor HCT","volume":"38","author":"Mehta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.020_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2991\/chi.d.200405.001","article-title":"Haploidentical hematopoietic stem cell transplantation followed by \u201cpost-cyclophosphamide\u201d: the future of allogeneic stem cell transplant","volume":"2","author":"Cytryn","year":"2020","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.jtct.2026.08.020_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-1-27","article-title":"Current status of haploidentical stem cell transplantation for leukemia","volume":"1","author":"Huang","year":"2008","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.020_bib0007","first-page":"505","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.020_bib0008","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/bloodadvances.2024014781","article-title":"PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation","volume":"9","author":"Desai","year":"2025","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.jtct.2026.08.020_bib0009","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.020_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa2503189","article-title":"Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin","volume":"393","author":"Curtis","year":"2025","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jtct.2026.08.020_bib0011","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/bloodadvances.2024013853","article-title":"Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations","volume":"8","author":"Mehta","year":"2024","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.020_bib0012","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1182\/bloodadvances.2019000050","article-title":"Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission","volume":"3","author":"Rashidi","year":"2019","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.jtct.2026.08.020_bib0013","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/bloodadvances.2019000614","article-title":"HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"3","author":"Meybodi","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.020_bib0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-020-00882-6","article-title":"Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT","volume":"13","author":"Sanz","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.020_bib0015","first-page":"395.e1","article-title":"Haploidentical versus matched unrelated versus matched sibling donor hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"28","author":"Mehta","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.020_bib0016","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jtct.2026.08.020_bib0017","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jtct.2026.08.020_bib0018","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2008.101","article-title":"The role of registries in facilitating clinical research in BMT: examples from the center for international blood and marrow transplant research","volume":"42","author":"Horowitz","year":"2008","journal-title":"Bone Marrow Transpl"},{"issue":"282","key":"10.1016\/j.jtct.2026.08.020_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.020_bib0020","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.020_bib0021","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1182\/bloodadvances.2023010755","article-title":"Haplo ever after: haplo PTCy for children","volume":"7","author":"Talano","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.020_bib0022","first-page":"313.e1","article-title":"Impact of post-transplantation cyclophosphamide on transfusion requirements in hla-matched sibling peripheral blood stem cell transplantation","volume":"29","author":"Marco-Ayala","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.020_bib0023","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/cncr.35365","volume":"130","author":"Bazarbachi","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2026.08.020_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/303487","article-title":"Haploidentical hematopoietic stem-cell transplantation in adults","volume":"2011","author":"Alshemmari","year":"2011","journal-title":"Bone Marrow Res"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.020_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-021-01094-2","article-title":"Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT","volume":"14","author":"Sanz","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"21","key":"10.1016\/j.jtct.2026.08.020_bib0026","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/bloodadvances.2019000236","article-title":"Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation","volume":"3","author":"Kwon","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.020_bib0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18620\/ctt-1866-8836-2017-6-4-52-59","article-title":"Single-agent post-transplantation cyclophosphamide versus calcineurin-based graft-versus-host disease prophylaxis in matched related bone marrow transplantation","volume":"6","author":"Moiseev","year":"2017","journal-title":"Cell Ther Transplant"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.020_bib0028","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.3390\/cancers17244029","article-title":"Complications of haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide-a prospective study on behalf of the EBMT transplant complications working party","volume":"17","author":"Tomaszewska","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.020_bib0029","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bbmt.2019.05.015","article-title":"Dynamic graft-versus-host disease-free, relapse-free survival: multistate modeling of the morbidity and mortality of allotransplantation","volume":"25","author":"Holtan","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.020_bib0030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41409-022-01725-3","article-title":"Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia","volume":"57","author":"Lazzari","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.08.020_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2025-171","article-title":"Matched unrelated vs. haploidentical donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis \u2013 a randomized prospective European trial","volume":"146","author":"Kroeger","year":"2025","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.020_bib0032","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3390\/cells13242067","article-title":"HLA and non-HLA factors for donor selection in hematopoietic stem cell transplantation with post-transplant cyclophosphamide GvHD prophylaxis","volume":"13","author":"Shike","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.020_bib0033","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41409-023-02042-z","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm","volume":"58","author":"Rieger","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.020_bib0034","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.bbmt.2013.12.038","article-title":"Infections are the major cause of non relapse mortality (NRM) after T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome","volume":"20","author":"Tamari","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.020_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-023-02131-z","article-title":"Post-transplantation cyclophosphamide is associated with increased bacterial infections","volume":"59","author":"Ustun","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.020_bib0036","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41409-019-0475-7","volume":"54","author":"Fayard","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.08.020_bib0037","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2018-99-111404","article-title":"Increased risk of 100-day and 1-year infection-related mortality in haploidentical stem cell transplantation patients","volume":"132","author":"Chang","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.020_bib0038","doi-asserted-by":"crossref","first-page":"538.e1","DOI":"10.1016\/j.jtct.2024.01.082","article-title":"Cytomegalovirus reactivations in allogeneic hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplantation cyclophosphamide","volume":"30","author":"Chor\u00e3o","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.020_bib0039","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1097\/TXD.0000000000001753","article-title":"Impact of granulocyte colony-stimulating factor (G-CSF) on clinical outcomes in allogeneic hematopoietic cell transplantation: does speeding up neutrophil engraftment make a difference?","volume":"11","author":"Alnughmush","year":"2025","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.020_bib0040","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/j.bbmt.2018.12.536","article-title":"Short course mycophenolate mofetil yields adequate immune reconstitution and equivalent alloreactivity following allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Al-Juhaishi","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"10.1016\/j.jtct.2026.08.020_bib0041","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2024014938","article-title":"Impact of Haplo-Donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation","volume":"9","author":"Nagayama","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.020_bib0042","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2016.10.017","article-title":"Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving cd34+selected grafts for allogeneic hematopoietic cell transplantation","volume":"23","author":"Barba","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.020_bib0043","first-page":"782.e1","volume":"27","author":"Arcuri","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.020_bib0044","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbmt.2008.02.005","article-title":"Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates","volume":"14","author":"Nakamura","year":"2008","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.020_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.020_bib48","series-title":"Contemporary Bone Marrow Transplantation","first-page":"1","article-title":"Infections in Hematopoietic Stem Cell Transplantation (HSCT) Patients","author":"George","year":"2020"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:10:36Z","timestamp":1789186236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S266663672600624X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}